Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine
- PMID: 11432968
- DOI: 10.1046/j.1471-4159.2001.00397.x
Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine
Abstract
To establish the possible roles of oxidative stress, inflammatory processes and other unknown mechanisms in neurodegeneration, we investigated brain gene alterations in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mice model of Parkinson's disease using Atlas mouse cDNA expression array membrane. The expression of 51 different genes involved in oxidative stress, inflammation, glutamate and neurotrophic factors pathways as well as in still undefined processes, such as cell cycle regulators and signal transduction molecules, was differentially affected by the treatment. The present study indicates the involvement of an additional cascade of events that might act in parallel to oxidative stress and inflammation to converge eventually into a common pathway leading to neurodegeneration. The attenuation of these gene changes by R-apomorphine, an iron chelator-radical scavenger drug, supports our previous findings in vivo where R-apomorphine was neuroprotective.
Similar articles
-
cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease.J Neural Transm Suppl. 2000;(60):117-24. doi: 10.1007/978-3-7091-6301-6_7. J Neural Transm Suppl. 2000. PMID: 11205134
-
Apomorphine protects against MPTP-induced neurotoxicity in mice.Mov Disord. 1999 Jul;14(4):612-8. doi: 10.1002/1531-8257(199907)14:4<612::aid-mds1010>3.0.co;2-6. Mov Disord. 1999. PMID: 10435498
-
Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.Neurochem Res. 2002 Oct;27(10):1231-43. doi: 10.1023/a:1020989812576. Neurochem Res. 2002. PMID: 12462421
-
What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?J Neural Transm Suppl. 2003;(65):73-88. doi: 10.1007/978-3-7091-0643-3_5. J Neural Transm Suppl. 2003. PMID: 12946050 Review.
-
Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine.J Neural Transm Suppl. 2000;(58):83-96. doi: 10.1007/978-3-7091-6284-2_7. J Neural Transm Suppl. 2000. PMID: 11128615 Review.
Cited by
-
Expression profiling to understand actions of NMDA/glutamate receptor antagonists in rat brain.Neurochem Res. 2002 Oct;27(10):1209-20. doi: 10.1023/a:1020985611667. Neurochem Res. 2002. PMID: 12462419
-
Molecular markers of early Parkinson's disease based on gene expression in blood.Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):955-60. doi: 10.1073/pnas.0610204104. Epub 2007 Jan 10. Proc Natl Acad Sci U S A. 2007. PMID: 17215369 Free PMC article.
-
Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes.Neurosci Bull. 2007 Mar;23(2):125-30. doi: 10.1007/s12264-007-0018-x. Neurosci Bull. 2007. PMID: 17592536 Free PMC article. Review.
-
Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its _target gene heme oxygenase-1.PLoS One. 2010 Jul 28;5(7):e11838. doi: 10.1371/journal.pone.0011838. PLoS One. 2010. PMID: 20676377 Free PMC article.
-
Microarrays in Parkinson's disease: a systematic approach.NeuroRx. 2006 Jul;3(3):319-26. doi: 10.1016/j.nurx.2006.05.008. NeuroRx. 2006. PMID: 16815215 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
